United States · FDA National Drug Code directory
OXCARBAZEPINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51991-292_7b71db65-df59-4739-9e8f-77aea32f80b3
- Product NDC
- 51991-292
- Form
- TABLET, FILM COATED
- Composition / generic term
- OXCARBAZEPINE
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20080111
- Source listing expiry
- 20261231
Source-listed ingredients
- OXCARBAZEPINE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (51991-292-01) · 51991-292-01
- 500 TABLET, FILM COATED in 1 BOTTLE (51991-292-05) · 51991-292-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →